Stay updated on VX15/Avelumab Combo in NSCLC Clinical Trial
Sign up to get notified when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.

Latest updates to the VX15/Avelumab Combo in NSCLC Clinical Trial page
- Check2 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedAdded a citation to iRECIST guidelines (Lancet Oncology 2017) in Publications and removed the Lancet Oncology 2019 erratum note from the same reference.SummaryDifference0.1%

- Check31 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check45 days agoChange DetectedUpdated the iRECIST citation to revision v3.4.3, replacing the previous v3.4.2 citation.SummaryDifference0.1%

- Check67 days agoChange DetectedA minor version update was applied: from v3.4.1 to v3.4.2, with no substantive content changes observed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check74 days agoChange DetectedRevision: v3.4.1 replaces v3.4.0 in the site's revision tag; this change is cosmetic and does not modify any study content or functionality. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to VX15/Avelumab Combo in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the VX15/Avelumab Combo in NSCLC Clinical Trial page.